title: Management of COPD in general practice in Denmark--participating in an educational program substantially improves adherence to guidelines.
abstract: OBJECTIVE
  The general practitioner (GP) is the first contact with the health care system for most patients with COPD in Denmark. We studied, if participating in an educational program could improve adherence to guidelines, not least for diagnosis, staging, and treatment of the disease.
  
  
  METHODS
  Two cross-sectional surveys were performed precisely one year apart before and after an educational program for the participating GPs. A total of 124 GPs completed the study; 1716 and 1342 patients with GP-diagnosed COPD and no concomitant asthma, respectively, were included in the two surveys.
  
  
  RESULTS
  The proportion of patients having FEV(1) registered in the GPs files increased from 45% to 69% (P < 0.001); and, furthermore, FEV(1) % of predicted was recorded in 30% and 56%, respectively, of the cases (P < 0.001). In line with this, significant improvements were also observed for registration of smoking status (69% to 85%), BMI (8% to 40%), severity of dyspnea (Medical Research Council) (7% to 38%), and FEV(1)/FVC ratio (28% to 58%) (P < 0.001). Concerning the management options, improvements were also observed with regard to antismoking counseling, inhalator technique, physical activity, and referral for rehabilitation; use of inhaled corticosteroids in patients with mild COPD (FEV(1) > 80%pred) declined from 76% to 45%.
  
  
  CONCLUSIONS
  Diagnosis and management of COPD in general practice in Denmark is not according to guidelines, but substantial improvements can be achieved by focused education of GPs and their staff.
authors.affiliation: Department of Cardiology and Respiratory Medicine, Hvidovre Hospital, Copenhagen, Denmark. csulrik@dadlnet.dk
authors.forename: Charlotte Suppli
authors.initials: CS
authors.lastname: Ulrik
authors.forename: Ejvind Frausing
authors.initials: EF
authors.lastname: Hansen
authors.forename: Michael Skov
authors.initials: MS
authors.lastname: Jensen
authors.forename: Finn Vejlø
authors.initials: FV
authors.lastname: Rasmussen
authors.forename: Jens
authors.initials: J
authors.lastname: Dollerup
authors.forename: Gert
authors.initials: G
authors.lastname: Hansen
authors.forename: Klaus Kaae
authors.initials: KK
authors.lastname: Andersen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D003718:Denmark; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D007318:Inservice Training; D008297:Male; D008875:Middle Aged; D010821:Physicians, Family / Q000193:education*; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy*
references.citation: Respir Med. 1999 Dec;93(12):903-8
references.pmid: 10653053
references.citation: Thorax. 1999 Jul;54(7):581-6
references.pmid: 10377201
references.citation: Pharmacoepidemiol Drug Saf. 2009 May;18(5):393-400
references.pmid: 19288473
references.citation: Bull Eur Physiopathol Respir. 1983 Jul;19 Suppl 5:1-95
references.pmid: 6616097
references.citation: Can Respir J. 2008 Jan-Feb;15(1):13-9
references.pmid: 18292848
references.citation: Thorax. 2004 Feb;59 Suppl 1:1-232
references.pmid: 15041752
references.citation: Monaldi Arch Chest Dis. 2005 Mar;63(1):6-12
references.pmid: 16035558
references.citation: Prim Care Respir J. 2007 Jun;16(3):174-81
references.pmid: 17516009
references.citation: Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):695-704
references.pmid: 17457948
references.citation: Thorax. 2006 Nov;61(11):935-9
references.pmid: 17071833
references.citation: Respir Med. 2005 Apr;99(4):493-500
references.pmid: 15763457
references.citation: Respir Res. 2008 Aug 18;9:62
references.pmid: 18710575